Paul J Seligman1. 1. Office of Pharmacoepidemiology and Statistical Science, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA. SELIGMANP@cder.fda.gov
Authors: Gabriel Sanfélix-Gimeno; Pedro Cervera-Casino; Salvador Peiró; Beatriz González López-Valcarcel; Amparo Blázquez; Teresa Barbera Journal: Drug Saf Date: 2009 Impact factor: 5.606